全文获取类型
收费全文 | 5217篇 |
免费 | 516篇 |
国内免费 | 1篇 |
出版年
2022年 | 31篇 |
2021年 | 56篇 |
2020年 | 35篇 |
2019年 | 45篇 |
2018年 | 43篇 |
2017年 | 50篇 |
2016年 | 101篇 |
2015年 | 179篇 |
2014年 | 170篇 |
2013年 | 244篇 |
2012年 | 321篇 |
2011年 | 361篇 |
2010年 | 221篇 |
2009年 | 200篇 |
2008年 | 282篇 |
2007年 | 335篇 |
2006年 | 305篇 |
2005年 | 321篇 |
2004年 | 325篇 |
2003年 | 298篇 |
2002年 | 328篇 |
2001年 | 70篇 |
2000年 | 50篇 |
1999年 | 86篇 |
1998年 | 83篇 |
1997年 | 74篇 |
1996年 | 62篇 |
1995年 | 53篇 |
1994年 | 65篇 |
1993年 | 63篇 |
1992年 | 53篇 |
1991年 | 40篇 |
1990年 | 42篇 |
1989年 | 44篇 |
1988年 | 44篇 |
1987年 | 44篇 |
1986年 | 36篇 |
1985年 | 35篇 |
1984年 | 52篇 |
1983年 | 39篇 |
1982年 | 43篇 |
1981年 | 46篇 |
1980年 | 36篇 |
1979年 | 29篇 |
1978年 | 35篇 |
1977年 | 36篇 |
1976年 | 36篇 |
1974年 | 23篇 |
1973年 | 39篇 |
1972年 | 25篇 |
排序方式: 共有5734条查询结果,搜索用时 31 毫秒
981.
982.
983.
Walter Jaoko Etienne Karita Kayitesi Kayitenkore Gloria Omosa-Manyonyi Susan Allen Soe Than Elizabeth M. Adams Barney S. Graham Richard A. Koup Robert T. Bailer Carol Smith Len Dally Bashir Farah Omu Anzala Claude M. Muvunyi Jean Bizimana Tony Tarragona-Fiol Philip J. Bergin Peter Hayes Martin Ho Kelley Loughran Wendy Komaroff Gwynneth Stevens Helen Thomson Mark J. Boaz Josephine H. Cox Claudia Schmidt Jill Gilmour Gary J. Nabel Patricia Fast Job Bwayo 《PloS one》2010,5(9)
Background
We conducted a double-blind, randomized, placebo-controlled Phase I study of a recombinant replication-defective adenovirus type 5 (rAd5) vector expressing HIV-1 Gag and Pol from subtype B and Env from subtypes A, B and C, given alone or as boost following a DNA plasmid vaccine expressing the same HIV-1 proteins plus Nef, in 114 healthy HIV-uninfected African adults.Methodology/Principal Findings
Volunteers were randomized to 4 groups receiving the rAd5 vaccine intramuscularly at dosage levels of 1×1010 or 1×1011 particle units (PU) either alone or as boost following 3 injections of the DNA vaccine given at 4 mg/dose intramuscularly by needle-free injection using Biojector® 2000. Safety and immunogenicity were evaluated for 12 months. Both vaccines were well-tolerated. Overall, 62% and 86% of vaccine recipients in the rAd5 alone and DNA prime - rAd5 boost groups, respectively, responded to the HIV-1 proteins by an interferon-gamma (IFN-γ) ELISPOT. The frequency of immune responses was independent of rAd5 dosage levels. The highest frequency of responses after rAd5 alone was detected at 6 weeks; after DNA prime - rAd5 boost, at 6 months (end of study). At baseline, neutralizing antibodies against Ad5 were present in 81% of volunteers; the distribution was similar across the 4 groups. Pre-existing immunity to Ad5 did not appear to have a significant impact on reactogenicity or immune response rates to HIV antigens by IFN-γ ELISPOT. Binding antibodies against Env were detected in up to 100% recipients of DNA prime - rAd5 boost. One volunteer acquired HIV infection after the study ended, two years after receipt of rAd5 alone.Conclusions/Significance
The HIV-1 rAd5 vaccine, either alone or as a boost following HIV-1 DNA vaccine, was well-tolerated and immunogenic in African adults. DNA priming increased the frequency and magnitude of cellular and humoral immune responses, but there was no effect of rAd5 dosage on immunogenicity endpoints.Trial Registration
ClinicalTrials.gov NCT00124007相似文献984.
Neural crest cells are pluripotent cells that emerge from the neural epithelium, migrate extensively and differentiate into numerous derivatives, including neurons, glial cells, pigment cells and connective tissue. Major questions concerning their morphogenesis include: (1) what establishes the pathways of migration? And (2), what controls the final destination and differentiation of various neural crest subpopulations? These questions will be addressed in this Review. Neural crest cells from the trunk level have been explored most extensively. Studies show that melanoblasts are specified shortly after they depart from the neural tube and this specification directs their migration into the dorsolateral pathway. We also consider other reports that present strong evidence for ventrally migrating neural crest cells being similarly fate restricted. Cranial neural crest cells have been less analyzed in this regard but the preponderance of evidence indicates that either the cranial neural crest cells are not fate-restricted or are extremely plastic in their developmental capability and that specification does not control pathfinding. Thus, the guidance mechanisms that control cranial neural crest migration and their behavior vary significantly from the trunk.The vagal neural crest arises at the axial level between the cranial and trunk neural crest and represents a transitional cell population between the head and trunk neural crest. We summarize new data to support this claim. In particular, we show that: (1) the vagal-level neural crest cells exhibit modest developmental bias; (2) there are differences in the migratory behavior between the anterior and the posterior vagal neural crest cells reminiscent of the cranial and the trunk neural crest, respectively and (3) the vagal neural crest cells take the dorsolateral pathway to the pharyngeal arches and the heart, but take the ventral pathway to the peripheral nervous system and the gut. However, these pathways are not rigidly specified because of prior fate restriction. Understanding the molecular, cellular and behavioral differences between these three populations of neural crest cells will be of enormous assistance when trying to understand the evolution of the neck.Key words: neural crest, morphogenesis, cell migration, chicken embryo, fate restriction, vagal neural crest, pathways 相似文献
985.
Huy Nguyen Cristy Loustaunau Alexander Facista Lois Ramsey Nadia Hassounah Hilary Taylor Robert Krouse Claire M. Payne V. Liana Tsikitis Steve Goldschmid Bhaskar Banerjee Rafael F. Perini Carol Bernstein 《Journal of visualized experiments : JoVE》2010,(41)
In carcinogenesis, the "field defect" is recognized clinically because of the high propensity of survivors of certain cancers to develop other malignancies of the same tissue type, often in a nearby location. Such field defects have been indicated in colon cancer. The molecular abnormalities that are responsible for a field defect in the colon should be detectable at high frequency in the histologically normal tissue surrounding a colonic adenocarcinoma or surrounding an adenoma with advanced neoplasia (well on the way to a colon cancer), but at low frequency in the colonic mucosa from patients without colonic neoplasia.Using immunohistochemistry, entire crypts within 10 cm on each side of colonic adenocarcinomas or advanced colonic neoplasias were found to be frequently reduced or absent in expression for two DNA repair proteins, Pms2 and/or ERCC1. Pms2 is a dual role protein, active in DNA mismatch repair as well as needed in apoptosis of cells with excess DNA damage. ERCC1 is active in DNA nucleotide excision repair. The reduced or absent expression of both ERCC1 and Pms2 would create cells with both increased ability to survive (apoptosis resistance) and increased level of mutability. The reduced or absent expression of both ERCC1 and Pms2 is likely an early step in progression to colon cancer.DNA repair gene Ku86 (active in DNA non-homologous end joining) and Cytochrome c Oxidase Subunit I (involved in apoptosis) had each been reported to be decreased in expression in mucosal areas close to colon cancers. However, immunohistochemical evaluation of their levels of expression showed only low to modest frequencies of crypts to be deficient in their expression in a field defect surrounding colon cancer or surrounding advanced colonic neoplasia.We show, here, our method of evaluation of crypts for expression of ERCC1, Pms2, Ku86 and CcOI. We show that frequency of entire crypts deficient for Pms2 and ERCC1 is often as great as 70% to 95% in 20 cm long areas surrounding a colonic neoplasia, while frequency of crypts deficient in Ku86 has a median value of 2% and frequency of crypts deficient in CcOI has a median value of 16% in these areas. The entire colon is 150 cm long (about 5 feet) and has about 10 million crypts in its mucosal layer. The defect in Pms2 and ERCC1 surrounding a colon cancer thus may include 1 million crypts. It is from a defective crypt that colon cancer arises. 相似文献
986.
987.
Lisa M. Tussing‐Humphreys Elizabeta Nemeth Giamila Fantuzzi Sally Freels Grace Guzman Ai‐Xuan L. Holterman Carol Braunschweig 《Obesity (Silver Spring, Md.)》2010,18(7):1449-1456
Hepcidin, the body's main regulator of systemic iron homeostasis, is upregulated in response to inflammation and is thought to play a role in the manifestation of iron deficiency (ID) observed in obese populations. We determined systemic hepcidin levels and its association with body mass, inflammation, erythropoiesis, and iron status in premenopausal obese and nonobese women (n = 20/group) matched for hemoglobin (Hb). The obese participants also had liver and abdominal visceral and subcutaneous adipose tissue assessed for tissue iron accumulation and hepcidin mRNA expression. Despite similar Hb levels, the obese women had significantly higher serum hepcidin (88.02 vs. 9.70 ng/ml; P < 0.0001) and serum transferrin receptor (sTfR) (P = 0.001) compared to nonobese. In the obese women hepcidin was not correlated with serum iron (r = ?0.02), transferrin saturation (Tsat) (r = 0.17) or sTfR (r = ?0.12); in the nonobese it was significantly positively correlated with Tsat (r = 0.70) and serum iron (r = 0.58), and inversely with sTfR (r = ?0.63). Detectable iron accumulation in the liver and abdominal adipose tissue of the obese women was minimal. Liver hepcidin mRNA expression was ~700 times greater than adipose tissue production and highly correlated with circulating hepcidin levels (r = 0.61). Serum hepcidin is elevated in obese women despite iron depletion, suggesting that it is responding to inflammation rather than iron status. The source of excess hepcidin appears to be the liver and not adipose tissue. The ID of obesity is predominantly a condition of a true body iron deficit rather than maldistribution of iron due to inflammation. However, these findings suggest inflammation may perpetuate this condition by hepcidin‐mediated inhibition of dietary iron absorption. 相似文献
988.
989.
Daniel J. Barnett Roger Levine Carol B. Thompson Gamunu U. Wijetunge Anthony L. Oliver Melissa A. Bentley Patrick D. Neubert Ronald G. Pirrallo Jonathan M. Links Ran D. Balicer 《PloS one》2010,5(3)